Scientific news

Cannabinoid drugs make pain feel 'less unpleasant, more tolerable'

Researchers have determined that cannabinoid drugs do not appear to reduce the intensity of experimental pain, but may make pain feel less unpleasant and more tolerable

Why Cronos Group's partnership to produce cultured cannabinoids could be a big deal

Earlier this month, Cronos Group entered into a partnership with Ginkgo Bioworks to develop cannabinoids using organism design and development technology

Bill approved by Congressional Committee, despite drug conviction restriction dispute

A powerful U.S. House panel that oversees federal drug enforcement efforts approved a bill to require the Department of Justice to begin issuing more licenses to grow cannabis for scientific research

U.S. chokehold on cannabis stymies studies on epilepsy, autism

Scientists' desire for evidence-based medical inquiry runs headlong into an apparently immovable obstacle: the U.S. Drug Enforcement Agency

GW Pharmaceuticals shares new data on Epidiolex at European Epilepsy Congress

Read about new data on Epidiolex recently presented by GW Pharmaceuticals during the 13th Annual European Congress of Epileptology

How uncontrolled inflammation leads to brain cell loss

New research finds the mechanisms that may drive inflammation in the brain, leading to the loss of neurons with age

Psychosis: cannabis extract normalises brain function

New research shows that a single dose of the cannabis extract cannabidiol reduces abnormal brain activity in people with psychosis

In test with rats, cannabidiol showed sustained effects against depression for seven days

The findings reinforce those of prior research showing that cannabidiol has promising therapeutic potential in the treatment of broad-spectrum depression in preclinical and human models

Cannabidiol (CBD) — what we know and what we don't

Cannabidiol (CBD) is an active ingredient in cannabis derived from the hemp plant and may help treat conditions like pain, insomnia, and anxiety

DEA is pushing to increase cannabis growth, reduce opioid prescriptions

In the face of a nation-wide epidemic of opioid abuse, the Drug Enforcement Administration seems to be changing its tune on cannabis